POS0065 AN IMMUNE-MOLECULAR SIGNATURE MODULATED BY JAK INHIBITORS EX VIVO PREDICTS IN VIVO THERAPY RESPONSE AND EXHIBITS SPECIFICITY COMPARED TO ANTI-TNF TREATMENTS IN RHEUMATOID ARTHRITIS | Publicación